BACKGROUND: The aim of this study was to understand any association between differentiated thyroid carcinoma (DTC) and Ile3434Thr XRCC7 gene polymorphism (GenBank accession number: rs7830743). DTC is the most prevalent thyroid neoplasm, which includes papillary and follicular cell carcinoma. XRCC7 gene encodes a protein that functions in non-homologous end joining DNA repair pathway. Non-synonymous polymorphisms in this gene may alter DNA repair capacity of the cell and change the risk of developing cancers. METHODS: DTC patients (n = 173) and cancer free individuals (n = 204) were enrolled in a case-control study. The Ile3434Thr polymorphic alleles were discriminated by using amplification refractory mutation system-PCR method. The frequencies of this single nucleotide polymorphism in case and control groups were compared. Also, risk ratio for developing DTC in dichotomized genotypes was estimated by multivariate logistic regression analysis. RESULTS: Dichotomized genotypes into those with and without the 3434Thr allele showed that this allele was associated with DTC (OR [odd ratio]: 1.89, 95% confidence interval (CI) = 1.29-2.79, P<0.001). Also, TC genotype was significantly associated with increased risk of DTC (OR: 2.42, 95% CI = 1.55-3.81, P = 0.0001) in individuals carrying this genotype. CONCLUSION: Allele 3434Thr in XRCC7 gene might be associated with differentiated thyroid cancer risk. Further studies with larger samples are needed to verify these initial findings.
BACKGROUND: The aim of this study was to understand any association between differentiated thyroid carcinoma (DTC) and Ile3434Thr XRCC7 gene polymorphism (GenBank accession number: rs7830743). DTC is the most prevalent thyroid neoplasm, which includes papillary and follicular cell carcinoma. XRCC7 gene encodes a protein that functions in non-homologous end joining DNA repair pathway. Non-synonymous polymorphisms in this gene may alter DNA repair capacity of the cell and change the risk of developing cancers. METHODS:DTCpatients (n = 173) and cancer free individuals (n = 204) were enrolled in a case-control study. The Ile3434Thr polymorphic alleles were discriminated by using amplification refractory mutation system-PCR method. The frequencies of this single nucleotide polymorphism in case and control groups were compared. Also, risk ratio for developing DTC in dichotomized genotypes was estimated by multivariate logistic regression analysis. RESULTS: Dichotomized genotypes into those with and without the 3434Thr allele showed that this allele was associated with DTC (OR [odd ratio]: 1.89, 95% confidence interval (CI) = 1.29-2.79, P<0.001). Also, TC genotype was significantly associated with increased risk of DTC (OR: 2.42, 95% CI = 1.55-3.81, P = 0.0001) in individuals carrying this genotype. CONCLUSION: Allele 3434Thr in XRCC7 gene might be associated with differentiated thyroid cancer risk. Further studies with larger samples are needed to verify these initial findings.
Entities:
Keywords:
DNA repair enzymes; Thyroid neoplasms; Genetic polymorphism
Authors: A K Siraj; M Al-Rasheed; M Ibrahim; K Siddiqui; F Al-Dayel; O Al-Sanea; S Uddin; K Al-Kuraya Journal: J Endocrinol Invest Date: 2008-10 Impact factor: 4.256
Authors: Mykola D Tronko; Geoffrey R Howe; Tetyana I Bogdanova; Andre C Bouville; Ovsiy V Epstein; Aaron B Brill; Illya A Likhtarev; Daniel J Fink; Valentyn V Markov; Ellen Greenebaum; Valery A Olijnyk; Ihor J Masnyk; Victor M Shpak; Robert J McConnell; Valery P Tereshchenko; Jacob Robbins; Oleksandr V Zvinchuk; Lydia B Zablotska; Maureen Hatch; Nickolas K Luckyanov; Elaine Ron; Terry L Thomas; Paul G Voillequé; Gilbert W Beebe Journal: J Natl Cancer Inst Date: 2006-07-05 Impact factor: 13.506
Authors: Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff Journal: Oncol Lett Date: 2018-02-21 Impact factor: 2.967
Authors: James P Lees-Miller; Alexander Cobban; Panagiotis Katsonis; Albino Bacolla; Susan E Tsutakawa; Michal Hammel; Katheryn Meek; Dave W Anderson; Olivier Lichtarge; John A Tainer; Susan P Lees-Miller Journal: Prog Biophys Mol Biol Date: 2020-10-06 Impact factor: 4.799